High Dose ESAs Are Associated with High iPTH Levels in Hemodialysis Patients with End-Stage Kidney Disease: A Retrospective Analysis

OBJECTIVE: Anemia and secondary hyperparathyroidism are the two most common complications associated with chronic kidney disease. Erythropoiesis-stimulating agents (ESAs) are widely used in the management of anemia in hemodialysis patients. A reverse correlation has been established between hyperpar...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Lan, Ling, Yi-Sheng, Lin, Chun-Hua, He, Jin-Xuan, Guan, Tian-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649021/
https://www.ncbi.nlm.nih.gov/pubmed/26636058
http://dx.doi.org/10.3389/fpubh.2015.00258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649021/
https://www.ncbi.nlm.nih.gov/pubmed/26636058
http://dx.doi.org/10.3389/fpubh.2015.00258

Ejemplares similares